GlaxoSmithKline Biologicals
Rixensart, Antwerpen, Belgium
Purpose
To characterize Klebsiella pneumoniae capsular (K) and sub-capsular (O) antigens among strains causing neonatal sepsis in low and middle-income countries
Division
Global Health
Date
October 2021
Region Served
GLOBAL
Committed amount
$1,239,825
Grant topic
Pneumonia & Pandemic Preparedness
Duration (months)
74
Grantee location
Rixensart, Antwerpen, Belgium
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.